Novartis AG (NYSE:NVS) Q3 2025 Earnings Call Transcript
Q3 2025 Earnings Call Transcript October 28, 2025 Novartis AG misses on earnings expectations. Reported EPS is $2.25 EPS, ...
Novartis Pharma AG: Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance
Ad hoc announcement pursuant to Art. 53 LR Q3 net sales grew +7% (cc1, +8% USD) and core operating income1 grew +7% (cc, +6% USD) Sales growth was driven by continued strong execution on priority ...
Precision Medicine Online
Novartis Hails Newer Drugs as Generics Temper Growth of Stalwarts in Q3
The firm is betting that treatments from new acquisitions, including its recent $12B bid for Avidity Biosciences, will ...
GlobalData on MSN
FDA approves UCB’s Kygevvi for genetic mitochondrial disease
The approval was based on data from a Phase II trial, two retrospective chart review studies and an expanded access programme ...
Healio
FDA approves Kygevvi for rare mitochondrial disorder
The FDA has approved a combination of doxecitine and doxribtimine to treat patients with thymidine kinase 2 deficiency for ...
Study supports wider use of FDA-approved drug for rare muscle disease
UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, ...
Healio
FDA approves expanded indication of Uzedy for bipolar I disorder
Please provide your email address to receive an email when new articles are posted on . Editor’s note: This is a developing news story. Please check back soon for updates. The FDA approved ...
Benzinga.com
FDA Expands Johnson & Johnson Ulcerative Colitis Drug Approval To Pediatric Patients
On Tuesday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s (NYSE:JNJ) Simponi (golimumab) for children with moderately to severely active ulcerative colitis (UC) who weigh at ...
Morningstar
AbbVie Gets Expanded FDA Approval for Rinvoq Drug
The Food & Drug Administration granted AbbVie expanded approval for its Rinvoq drug intended to treat moderately to severely active ulcerative colitis and moderately to severely active Crohn's disease ...
Medscape
FDA Expands Uzedy Indication to Bipolar I Disorder
The FDA has approved an expanded indication for risperidone (Uzedy, Teva) extended-release injectable suspension, allowing it to be used for the maintenance treatment of bipolar I disorder in adults, ...
FDA approves non-hormonal medication for menopause symptoms
The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause ...